Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 9/20 | 1.00 |
| ▸ | SRC | P12931 | 4/20 | 1.00 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7993742 | 0.98 | FGFR1 (0.97) | FGFR1SRCHTTEGLN1 | |
| SCHEMBL7989967 | 0.83 | FGFR1 (0.71) | FGFR1SRCHTTEGLN1 | |
| SCHEMBL7986692 | 0.82 | FGFR1 (0.70) | FGFR1SRCHTTEGLN1 | |
| Hydrochloric Acid SCHEMBL7993360 | 0.82 | FGFR1 (0.69) | FGFR1SRCHTTEGLN1 | |
| Hydrochloric Acid SCHEMBL7987545 | 0.81 | FGFR1 (0.68) | FGFR1SRCHTTEGLN1 | |
| SCHEMBL7975887 | 0.80 | SRC (1.00) | FGFR1SRCHTT | |
| SCHEMBL7975839 | 0.80 | SRC (0.66) | FGFR1SRCHTT | |
| Hydrochloric Acid SCHEMBL7989583 | 0.79 | SRC (0.97) | FGFR1SRCHTT | |
| Hydrochloric Acid SCHEMBL7975678 | 0.79 | SRC (0.64) | FGFR1SRCHTT | |
| SCHEMBL5469956 | 0.72 | FGFR1 (0.57) | FGFR1SRCHTTEGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6218388-B1 | THERAPY OF PROTEIN TYROSINE KINASE MEDIATED CANCER, ATHEROSCLEROSIS, RESTENOSIS, AND PSORIASIS BY ADMINISTERING BENZIMIDAZOLE DERIVATIVE | WARNER-LAMBERT COMPANY | 2001-04-17 | — | — | US | disclosed |
| US-5990146-A | TREATING PROTEIN TYROSINE KINASE MEDIATED CANCER; ANTICARCINOGENIC AGENTS; ATHEROSCLEROSIS; RESTENOSIS; PSORIASIS; ANTIPROLIFERATIVE AGENTS | WARNER-LAMBERT COMPANY (US) | 1999-11-23 | — | — | US | disclosed |